The influence of single and combined IL28B polymorphisms on response to treatment of chronic hepatitis C

Results of this study confirm that all investigated IL28B polymorphisms are associated with treatment response and that presence of any of the favourable IL28B genotypes can be considered independent pretreatment determinant of the effectiveness of therapy.